litlas
ログインアカウント作成

Richard E. Pratley

1992–2026 年に発表

249
論文数
58,317
被引用数
121
h 指数
240
i10 指数

被引用数

Richard E. Pratley の年別被引用数1969 年: 被引用 1 件1986 年: 被引用 1 件1990 年: 被引用 1 件1993 年: 被引用 1 件1994 年: 被引用 9 件1995 年: 被引用 22 件1996 年: 被引用 65 件1997 年: 被引用 127 件1998 年: 被引用 142 件1999 年: 被引用 128 件2000 年: 被引用 224 件2001 年: 被引用 233 件2002 年: 被引用 282 件2003 年: 被引用 430 件2004 年: 被引用 409 件2005 年: 被引用 411 件2006 年: 被引用 388 件2007 年: 被引用 356 件2008 年: 被引用 326 件2009 年: 被引用 316 件2010 年: 被引用 272 件2011 年: 被引用 310 件2012 年: 被引用 276 件2013 年: 被引用 301 件2014 年: 被引用 279 件2015 年: 被引用 292 件2016 年: 被引用 229 件2017 年: 被引用 214 件2018 年: 被引用 241 件2019 年: 被引用 886 件2020 年: 被引用 955 件2021 年: 被引用 1,289 件2022 年: 被引用 1,233 件2023 年: 被引用 1,629 件2024 年: 被引用 4,197 件2025 年: 被引用 2,222 件2026 年: 被引用 85 件1970〜1985 年は被引用が無いため表示していません1987〜1989 年は被引用が無いため表示していません1991〜1992 年は被引用が無いため表示していません

引用元

国・地域

この著者を引用した国・地域の世界地図アメリカ合衆国: 引用元論文 6,028 件、この内訳の 25.2%中国: 引用元論文 1,791 件、この内訳の 7.5%イギリス: 引用元論文 1,697 件、この内訳の 7.1%イタリア: 引用元論文 1,230 件、この内訳の 5.1%カナダ: 引用元論文 1,015 件、この内訳の 4.3%ドイツ: 引用元論文 981 件、この内訳の 4.1%オーストラリア: 引用元論文 809 件、この内訳の 3.4%デンマーク: 引用元論文 690 件、この内訳の 2.9%スペイン: 引用元論文 644 件、この内訳の 2.7%日本: 引用元論文 623 件、この内訳の 2.6%スウェーデン: 引用元論文 591 件、この内訳の 2.5%フランス: 引用元論文 579 件、この内訳の 2.4%
0%25.2%その他 30.2%

機関

分野

  • Medicine75.2%
  • Biochemistry, Genetics and Molecular Biology10%
  • Neuroscience8.4%
  • Nursing1.4%
  • Health Professions1.2%
  • Psychology1%
  • その他2.8%

トピック

  • Diabetes Treatment and Management9.3%
  • Adipokines, Inflammation, and Metabolic Diseases5.3%
  • Diabetes Management and Research4.7%
  • Regulation of Appetite and Obesity4%
  • Pancreatic function and diabetes3.9%
  • Adipose Tissue and Metabolism3.7%
  • その他69.1%

共著者

全論文

検索で開く
  1. 2. Classification and Diagnosis of Diabetes:Standards of Care in Diabetes—2023

    著者: Nuha A. ElSayed, Grazia Aleppo, Vanita R. Aroda, Raveendhara R. Bannuru, Florence M. Brown, Dennis Bruemmer, Billy S. Collins, Jason L. Gaglia, Marisa E. Hilliard, Diana Isaacs, Eric L. Johnson, Scott Kahan, Kamlesh Khunti, José León, Sarah K. Lyons, Mary Lou Perry, Priya Prahalad, Richard E. Pratley, Jane Jeffrie Seley, Robert C. Stanton, Robert A. Gabbay - Diabetes Care 2022 被引用: 2,390

  2. Cardiovascular, mortality, and kidney outcomes with GLP-1 receptor agonists in patients with type 2 diabetes: a systematic review and meta-analysis of randomised trials

    著者: Naveed Sattar, Matthew M.Y. Lee, Søren Lund Kristensen, Kelley R. Branch, Stefano Del Prato, Nardev S. Khurmi, Carolyn S.P. Lam, Renato D. Lópes, John J.V. McMurray, Richard E. Pratley, Julio Rosenstock, Hertzel C. Gerstein - The Lancet Diabetes & Endocrinology 2021 被引用: 1,502

  3. 2. Diagnosis and Classification of Diabetes:Standards of Care in Diabetes—2024

    著者: Nuha A. ElSayed, Grazia Aleppo, Raveendhara R. Bannuru, Dennis Bruemmer, Billy S. Collins, Laya Ekhlaspour, Jason L. Gaglia, Marisa E. Hilliard, Eric L. Johnson, Kamlesh Khunti, Ildiko Lingvay, Glenn Matfin, Rozalina G. McCoy, Mary Lou Perry, Scott J. Pilla, Sarit Polsky, Priya Prahalad, Richard E. Pratley, Alissa R. Segal, Jane Jeffrie Seley, Elizabeth Selvin, Robert C. Stanton, Robert A. Gabbay - Diabetes Care 2023 被引用: 1,770

  4. 9. Pharmacologic Approaches to Glycemic Treatment: Standards of Care in Diabetes—2023

    著者: Nuha A. ElSayed, Grazia Aleppo, Vanita R. Aroda, Raveendhara R. Bannuru, Florence M. Brown, Dennis Bruemmer, Billy S. Collins, Marisa E. Hilliard, Diana Isaacs, Eric L. Johnson, Scott Kahan, Kamlesh Khunti, José León, Sarah K. Lyons, Mary Lou Perry, Priya Prahalad, Richard E. Pratley, Jane Jeffrie Seley, Robert C. Stanton, Robert A. Gabbay - Diabetes Care 2022 被引用: 851

  5. Association of SGLT2 Inhibitors With Cardiovascular and Kidney Outcomes in Patients With Type 2 Diabetes

    著者: Darren K. McGuire, Weichung Shih, Francesco Cosentino, B Charbonnel, David Z.I. Cherney, Samuel Dagogo‐Jack, Richard E. Pratley, Michelle Greenberg, Shuai Wang, Susan Huyck, Ira Gantz, Steven G. Terra, Urszula Masiukiewicz, Christopher P. Cannon - JAMA Cardiology 2020 被引用: 1,212

  6. Cardiovascular and Renal Outcomes with Efpeglenatide in Type 2 Diabetes

    著者: Hertzel C. Gerstein, Naveed Sattar, Julio Rosenstock, Chinthanie Ramasundarahettige, Richard E. Pratley, Renato D. Lópes, Carolyn S.P. Lam, Nardev S. Khurmi, Laura Heenan, Stefano Del Prato, Leanne Dyal, Kelley R. Branch - New England Journal of Medicine 2021 被引用: 777

  7. Cardiovascular Outcomes with Ertugliflozin in Type 2 Diabetes

    著者: Christopher P. Cannon, Richard E. Pratley, Samuel Dagogo‐Jack, James P. Mancuso, Susan Huyck, Urszula Masiukiewicz, B Charbonnel, Robert Frederich, Silvina Gallo, Francesco Cosentino, Weichung Shih, Ira Gantz, Steven G. Terra, David Z.I. Cherney, Darren K. McGuire - New England Journal of Medicine 2020 被引用: 1,496

  8. 9. Pharmacologic Approaches to Glycemic Treatment: Standards of Care in Diabetes—2024

    著者: Nuha A. ElSayed, Grazia Aleppo, Raveendhara R. Bannuru, Dennis Bruemmer, Billy S. Collins, Laya Ekhlaspour, Jason L. Gaglia, Marisa E. Hilliard, Eric L. Johnson, Kamlesh Khunti, Ildiko Lingvay, Glenn Matfin, Rozalina G. McCoy, Mary Lou Perry, Scott J. Pilla, Sarit Polsky, Priya Prahalad, Richard E. Pratley, Alissa R. Segal, Jane Jeffrie Seley, Robert C. Stanton, Robert A. Gabbay - Diabetes Care 2023 被引用: 627

  9. 6. Glycemic Targets: Standards of Care in Diabetes—2023

    著者: Nuha A. ElSayed, Grazia Aleppo, Vanita R. Aroda, Raveendhara R. Bannuru, Florence M. Brown, Dennis Bruemmer, Billy S. Collins, Marisa E. Hilliard, Diana Isaacs, Eric L. Johnson, Scott Kahan, Kamlesh Khunti, José León, Sarah K. Lyons, Mary Lou Perry, Priya Prahalad, Richard E. Pratley, Jane Jeffrie Seley, Robert C. Stanton, Robert A. Gabbay - Diabetes Care 2022 被引用: 683

  10. 10. Cardiovascular Disease and Risk Management: Standards of Care in Diabetes—2023

    著者: Nuha A. ElSayed, Grazia Aleppo, Vanita R. Aroda, Raveendhara R. Bannuru, Florence M. Brown, Dennis Bruemmer, Billy S. Collins, Sandeep R. Das, Marisa E. Hilliard, Diana Isaacs, Eric L. Johnson, Scott Kahan, Kamlesh Khunti, Mikhail Kosiborod, José León, Sarah K. Lyons, Mary Lou Perry, Priya Prahalad, Richard E. Pratley, Jane Jeffrie Seley, Robert C. Stanton, Robert A. Gabbay - Diabetes Care 2022 被引用: 463

  11. Semaglutide versus dulaglutide once weekly in patients with type 2 diabetes (SUSTAIN 7): a randomised, open-label, phase 3b trial

    著者: Richard E. Pratley, Vanita R. Aroda, Ildiko Lingvay, J Lüdemann, Camilla Andreassen, Andrea Navarria, Adie Viljoen - The Lancet Diabetes & Endocrinology 2018 被引用: 764

  12. 10. Cardiovascular Disease and Risk Management: Standards of Care in Diabetes—2024

    著者: Nuha A. ElSayed, Grazia Aleppo, Raveendhara R. Bannuru, Dennis Bruemmer, Billy S. Collins, Sandeep R. Das, Laya Ekhlaspour, Marisa E. Hilliard, Eric L. Johnson, Kamlesh Khunti, Mikhail Kosiborod, Ildiko Lingvay, Glenn Matfin, Rozalina G. McCoy, Mary Lou Perry, Scott J. Pilla, Sarit Polsky, Priya Prahalad, Richard E. Pratley, Alissa R. Segal, Jane Jeffrie Seley, Robert C. Stanton, Robert A. Gabbay - Diabetes Care 2023 被引用: 413

  13. Oral semaglutide versus subcutaneous liraglutide and placebo in type 2 diabetes (PIONEER 4): a randomised, double-blind, phase 3a trial

    著者: Richard E. Pratley, Aslam Amod, Søren T. Hoff, Takashi Kadowaki, Ildiko Lingvay, Michael A. Nauck, Karen Boje Pedersen, Trine Saugstrup, Juris J. Meier - The Lancet 2019 被引用: 583

  14. 6. Glycemic Goals and Hypoglycemia: Standards of Care in Diabetes—2024

    著者: Nuha A. ElSayed, Grazia Aleppo, Raveendhara R. Bannuru, Dennis Bruemmer, Billy S. Collins, Laya Ekhlaspour, Marisa E. Hilliard, Eric L. Johnson, Kamlesh Khunti, Ildiko Lingvay, Glenn Matfin, Rozalina G. McCoy, Mary Lou Perry, Scott J. Pilla, Sarit Polsky, Priya Prahalad, Richard E. Pratley, Alissa R. Segal, Jane Jeffrie Seley, Elizabeth Selvin, Robert C. Stanton, Robert A. Gabbay - Diabetes Care 2023 被引用: 444

  15. GLP-1 Analogs and DPP-4 Inhibitors in Type 2 Diabetes Therapy: Review of Head-to-Head Clinical Trials

    著者: Matthew P. Gilbert, Richard E. Pratley - Frontiers in Endocrinology 2020 被引用: 382

  16. 7. Diabetes Technology: Standards of Care in Diabetes—2024

    著者: Nuha A. ElSayed, Grazia Aleppo, Raveendhara R. Bannuru, Dennis Bruemmer, Billy S. Collins, Laya Ekhlaspour, Marisa E. Hilliard, Eric L. Johnson, Kamlesh Khunti, Ildiko Lingvay, Glenn Matfin, Rozalina G. McCoy, Mary Lou Perry, Scott J. Pilla, Sarit Polsky, Priya Prahalad, Richard E. Pratley, Alissa R. Segal, Jane Jeffrie Seley, Robert C. Stanton, Robert A. Gabbay - Diabetes Care 2023 被引用: 266

  17. 15. Management of Diabetes in Pregnancy:Standards of Care in Diabetes—2023

    著者: Nuha A. ElSayed, Grazia Aleppo, Vanita R. Aroda, Raveendhara R. Bannuru, Florence M. Brown, Dennis Bruemmer, Billy S. Collins, Marisa E. Hilliard, Diana Isaacs, Eric L. Johnson, Scott Kahan, Kamlesh Khunti, José León, Sarah K. Lyons, Mary Lou Perry, Priya Prahalad, Richard E. Pratley, Jane Jeffrie Seley, Robert C. Stanton, Robert A. Gabbay - Diabetes Care 2022 被引用: 280

  18. 5. Facilitating Positive Health Behaviors and Well-being to Improve Health Outcomes:Standards of Care in Diabetes—2023

    著者: Nuha A. ElSayed, Grazia Aleppo, Vanita R. Aroda, Raveendhara R. Bannuru, Florence M. Brown, Dennis Bruemmer, Billy S. Collins, Marisa E. Hilliard, Diana Isaacs, Eric L. Johnson, Scott Kahan, Kamlesh Khunti, José León, Sarah K. Lyons, Mary Lou Perry, Priya Prahalad, Richard E. Pratley, Jane Jeffrie Seley, Robert C. Stanton, Deborah Lee Young-Hyman, Robert A. Gabbay - Diabetes Care 2022 被引用: 372

  19. 11. Chronic Kidney Disease and Risk Management: Standards of Care in Diabetes—2024

    著者: Nuha A. ElSayed, Grazia Aleppo, Raveendhara R. Bannuru, Dennis Bruemmer, Billy S. Collins, Laya Ekhlaspour, Marisa E. Hilliard, Eric L. Johnson, Kamlesh Khunti, Ildiko Lingvay, Glenn Matfin, Rozalina G. McCoy, Mary Lou Perry, Scott J. Pilla, Sarit Polsky, Priya Prahalad, Richard E. Pratley, Alissa R. Segal, Jane Jeffrie Seley, Robert C. Stanton, Robert A. Gabbay - Diabetes Care 2023 被引用: 255

  20. Efficacy and safety of oral semaglutide in patients with type 2 diabetes and moderate renal impairment (PIONEER 5): a placebo-controlled, randomised, phase 3a trial

    著者: Ofri Mosenzon, Thalia Marie Blicher, Signe Rosenlund, Jan W. Eriksson, Simon Heller, Ole Hels, Richard E. Pratley, Thozhukat Sathyapalan, Cyrus Desouza, R.N. Abramof, Diana N Alpenidze, S Aronoff, K. Astamirova, B Barker, Gary Bedel, Lidia Belousova, Mark D. Benson, Isaac Beshay, William Biggs, Kenneth Blaze, Paweł Bogdański, Robert S. Busch, Sushela Chaidarun, Siddharthan Chandran, Alex R. Chang, S Chilka, Alan S. Cleland, Lisa Connery, George Mitchell Cornett, Bruno Delgado, Cyrus Desouza, Thomas Donner, Ken Eliasson, Jan W. Eriksson, Steven Folkerth, Kristy Forshaw, Hans Frandsen, Elena Frolova, Winston Gandy, G Gatipon, Albina Golovach, L. Gonzalez-Orozco, Janusz Gumprecht, Élie Haddad, Troels Krarup Hansen, Thomas C. Hart, Syed Shahzad Hasan, Brent Hella, Simon Heller, Margareta Hellgren, Mark I. Hewitt, S Hietaniemi, Marc‐Phillip Hitz, P Houser, Raphael E. Huntley, R. A. JACKSON, Poul Erik Jakobsen, Anuj Pal Kapoor, L. Kargina, Elena Kazakova, Khalid Khan, E. Klein, H Knoble, N Krasnopeeva, Andre Krzeminski, М. А. Куницына, J Lawhead, Klaus Levin, Philip Levin, Lorena Lewy-Alterbaum, Stina Lindmark, Robert S. Lindsay, Alain Luts, Tatyana Lysenko, Sten Madsbad, Tyler Maxwell, Caroline Mbogua, JA McKnight, Kaj Metsärinne, Т. А. Милованова, Emily Morawski, Ofri Mosenzon, Dan Nabriski, Hai Quy Tram Nguyen, Philip Nicol, Sanna Nieminen, Anita Schwab Nikkola, Paul Norwood, Peter H. O’Donnell, A. Ola Odugbesan, Jeremy C. Parker, Y. Pergaeva, А. Б. Песков, S. Plevin, Joe Pouzar, Richard E. Pratley, Josh Reed, Peter Rossing, Thozhukat Sathyapalan, M. Sergeeva-Kondrachenko ほか 16 名 - The Lancet Diabetes & Endocrinology 2019 被引用: 342

  21. 8. Obesity and Weight Management for the Prevention and Treatment of Type 2 Diabetes: Standards of Care in Diabetes–2024

    著者: Nuha A. ElSayed, Grazia Aleppo, Raveendhara R. Bannuru, Dennis Bruemmer, Billy S. Collins, Laya Ekhlaspour, Marisa E. Hilliard, Eric L. Johnson, Kamlesh Khunti, Robert F. Kushner, Ildiko Lingvay, Glenn Matfin, Rozalina G. McCoy, Mary Lou Perry, Scott J. Pilla, Sarit Polsky, Priya Prahalad, Richard E. Pratley, Alissa R. Segal, Jane Jeffrie Seley, Robert C. Stanton, Robert A. Gabbay - Diabetes Care 2023 被引用: 189

  22. Effect of Continuous Glucose Monitoring on Hypoglycemia in Older Adults With Type 1 Diabetes

    著者: Richard E. Pratley, Lauren Kanapka, Michael R. Rickels, Andrew Ahmann, Grazia Aleppo, Roy W. Beck, Anuj Bhargava, Bruce W. Bode, Anders L. Carlson, Naomi Chaytor, D. Steven Fox, Robin Goland, Irl B. Hirsch, Davida Kruger, Yogish C. Kudva, Carol J. Levy, Janet B. McGill, Anne L. Peters, Louis H. Philipson, Athena Philis‐Tsimikas, Rodica Pop‐Busui, Viral N. Shah, Michael Thompson, Francesco Vendrame, Alandra Verdejo, Ruth S. Weinstock, Laura Young, Kellee M. Miller, for the Wireless Innovation for Seniors With Diabetes Mellitus (WISDM) Study Group - JAMA 2020 被引用: 353

  23. 8. Obesity and Weight Management for the Prevention and Treatment of Type 2 Diabetes: Standards of Care in Diabetes—2023

    著者: Nuha A. ElSayed, Grazia Aleppo, Vanita R. Aroda, Raveendhara R. Bannuru, Florence M. Brown, Dennis Bruemmer, Billy S. Collins, Marisa E. Hilliard, Diana Isaacs, Eric L. Johnson, Scott Kahan, Kamlesh Khunti, José León, Sarah K. Lyons, Mary Lou Perry, Priya Prahalad, Richard E. Pratley, Jane Jeffrie Seley, Robert C. Stanton, Robert A. Gabbay - Diabetes Care 2022 被引用: 241

  24. 11. Chronic Kidney Disease and Risk Management: Standards of Care in Diabetes—2023

    著者: Nuha A. ElSayed, Grazia Aleppo, Vanita R. Aroda, Raveendhara R. Bannuru, Florence M. Brown, Dennis Bruemmer, Billy S. Collins, Marisa E. Hilliard, Diana Isaacs, Eric L. Johnson, Scott Kahan, Kamlesh Khunti, José León, Sarah K. Lyons, Mary Lou Perry, Priya Prahalad, Richard E. Pratley, Jane Jeffrie Seley, Robert C. Stanton, Robert A. Gabbay - Diabetes Care 2022 被引用: 283